INZY

Inozyme Pharma (INZY)

About Inozyme Pharma (INZY)

Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company. It engages in the business of developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company was founded by Axel Bolte, Joseph P. Schlessinger, and Demetrios T. Braddock in September 2015 and is headquartered in Boston, MA.

Details

Daily high

$5.30

Daily low

$5.12

Price at open

$5.19

52 Week High

$7.80

52 Week Low

$2.69

Market cap

329.4M

Dividend yield

0.00%

Volume

115,626

Avg. volume

193,095

P/E ratio

-3.61

Inozyme Pharma News